Study to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or Perimenopausal Patients With Advanced or Metastatic Breast Cancer
Clinical trial NCT03839823 · COMPLETED
Trial details
- NCT number
- NCT03839823
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-25
- Primary completion
- 2022-04-12
- Enrollment
- 222
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.